The FDA has approved updated COVID-19 vaccines from Pfizer, Moderna, and Novavax, but only for people at higher risk of severe illness. These vaccines target a common coronavirus strain and are available for those who consult with their doctors. The FDA also ended emergency use authorizations for COVID-19 vaccines in certain groups, meaning they are no longer mandatory. Pfizer’s booster is approved for ages 5–64 with health conditions, Moderna’s for ages 6 months–64, and Novavax’s for ages 12–64. All three are approved for adults 65 and older. The FDA recommends these vaccines for the 2025–2026 fall and winter seasons. However, access may be more limited than before, as the approval now focuses on high-risk individuals. For children under 5, only Moderna’s vaccine is available. Some medical groups, like the Infectious Diseases Society of America, disagree with the FDA’s decision, saying it limits vaccine access unfairly. The CDC still recommends COVID-19 vaccines for most adults and advises parents to discuss vaccination with their doctors. Pfizer and Moderna will start shipping their vaccines soon.